News
The Inflation Reduction Act could lower out-of-pocket costs by around $7.4 billion in 2025 for more than a third of all Americans enrolled in Medicare Part D, according to a ...
New data on an injectable form of Eisai's Alzheimer's drug, Leqembi, showed that it was more effective than an intravenous version at clearing amyloid but also came with a higher ...
GE HealthCare hits the road in a health tech bus to bring its latest solutions to hospital doorsteps
GE HealthCare is crisscrossing the country in a big purple bus to introduce hospital teams to some of its newest healthcare technologies.
Galderma’s annual push, and funding donation, for breast cancer awareness during October this year is focused on the personal stories of survivors who’ve used its aesthetics products to feel ...
Argenx looks for quick label expansion for subcutaneous Vyvgart with PhII data — shares soar ...
UnitedHealth Group’s Optum is shutting down its virtual care business, Endpoints News has learned. Known as Optum Virtual Care, the business provides online urgent and primary care visits and ...
Novo Nordisk spelled out how it will try to catch up with the extraordinary demand for its GLP-1 drugs, underscoring its rationale for its in-house API production and strategic fill ...
Eli Lilly will pay up to $1.925 billion in cash for weight loss drugmaker Versanis, marking the Big Pharma’s fourth acquisition this summer after deals for DICE Therapeutics, Sigilon and ...
The FDA is hoping its latest solution will stave off the continued shortage of cisplatin, a key drug used in treating several types of cancer. Beginning ...
Vertex sued the federal government on Monday in an effort to expand its fertility support program to certain patients taking its new gene therapy for sickle cell disease and transfusion ...
French biotech Smart Immune has raised more than half of its roughly €50 million ($54 million) target in an ongoing Series A round, with an eye to completing Phase I ...
Gene therapy startup enGene became a public biotech on Wednesday after completing its combination with Forbion European Acquisition, a blank check company formed in 2021. The Montreal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results